Literature DB >> 28792873

Acute Respiratory Distress Syndrome.

B Taylor Thompson1, Rachel C Chambers1, Kathleen D Liu1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28792873     DOI: 10.1056/NEJMra1608077

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  422 in total

1.  Acute respiratory distress syndrome (ARDS) phenotyping.

Authors:  M Shankar-Hari; E Fan; N D Ferguson
Journal:  Intensive Care Med       Date:  2018-12-05       Impact factor: 17.440

2.  Single cell RNA sequencing identifies an early monocyte gene signature in acute respiratory distress syndrome.

Authors:  Yale Jiang; Brian R Rosborough; Jie Chen; Sudipta Das; Georgios D Kitsios; Bryan J McVerry; Rama K Mallampalli; Janet S Lee; Anuradha Ray; Wei Chen; Prabir Ray
Journal:  JCI Insight       Date:  2020-07-09

3.  Regulatory role of Gpr84 in the switch of alveolar macrophages from CD11blo to CD11bhi status during lung injury process.

Authors:  Chengcong Yin; Long Cheng; Jiajia Pan; Lili Chen; Qi Xue; Juliang Qin; Shaoying Wang; Bing Du; Mingyao Liu; Ying Zhang; Wenzheng Jiang; Min Qian; Hua Ren
Journal:  Mucosal Immunol       Date:  2020-07-27       Impact factor: 7.313

4.  Case Report: Typhoid Fever Complicated by Acute Respiratory Distress Syndrome in a Pediatric Traveler.

Authors:  Morgan Birabaharan; Mundeep K Kainth; Aaron D Kessel; Stefan H F Hagmann
Journal:  Am J Trop Med Hyg       Date:  2019-08       Impact factor: 2.345

5.  Alternative RNA splicing and alternative transcription start/end in acute respiratory distress syndrome.

Authors:  Alger M Fredericks; Li Juan Wang; William G Fairbrother; Alfred Ayala; Sean F Monaghan
Journal:  Intensive Care Med       Date:  2020-02-20       Impact factor: 17.440

6.  Delayed Akt suppression in the lipopolysaccharide-induced acute lung injury promotes resolution that is associated with enhanced effector regulatory T cells.

Authors:  Sandeep Artham; Arti Verma; Abdulrahman Alwhaibi; Mir S Adil; Santhakumar Manicassamy; David H Munn; Payaningal R Somanath
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-02-19       Impact factor: 5.464

7.  Transcriptional analysis of Foxp3+ Tregs and functions of two identified molecules during resolution of ALI.

Authors:  Jason R Mock; Catherine F Dial; Miriya K Tune; Dustin L Norton; Jessica R Martin; John C Gomez; Robert S Hagan; Hong Dang; Claire M Doerschuk
Journal:  JCI Insight       Date:  2019-03-21

8.  Computational Modeling of Primary Blast Lung Injury: Implications for Ventilator Management.

Authors:  Jacob Herrmann; Merryn H Tawhai; David W Kaczka
Journal:  Mil Med       Date:  2019-03-01       Impact factor: 1.437

9.  Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.

Authors:  Carolyn S Calfee; Kevin L Delucchi; Pratik Sinha; Michael A Matthay; Jonathan Hackett; Manu Shankar-Hari; Cliona McDowell; John G Laffey; Cecilia M O'Kane; Daniel F McAuley
Journal:  Lancet Respir Med       Date:  2018-08-02       Impact factor: 30.700

10.  Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial.

Authors:  Michael A Matthay; Carolyn S Calfee; Hanjing Zhuo; B Taylor Thompson; Jennifer G Wilson; Joseph E Levitt; Angela J Rogers; Jeffrey E Gotts; Jeanine P Wiener-Kronish; Ednan K Bajwa; Michael P Donahoe; Bryan J McVerry; Luis A Ortiz; Matthew Exline; John W Christman; Jason Abbott; Kevin L Delucchi; Lizette Caballero; Melanie McMillan; David H McKenna; Kathleen D Liu
Journal:  Lancet Respir Med       Date:  2018-11-16       Impact factor: 30.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.